You have 9 free searches left this month | for more free features.

Condition

HIV-1 Infection (1)

HIV-1-infection (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2/phase 3 (1)

Sponsor

Gilead Sciences (2)

Collaborator

Intervention

lenacapavir (2)

b/f/taf (1)

bic/len fdc (1)

bictegravir (1)

placebo (1)

stable baseline regimen (1)

taf (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

lenacapavir

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HIV-1-infection Trial (Bictegravir, Lenacapavir, BIC/LEN FDC)

Not yet recruiting

HIV-1-infection

Bictegravir
+3 more

(no location specified)

Aug 12, 2022

HIV-1 Infection Trial in United States (Lenacapavir, Placebo, B/F/TAF)

Completed

HIV-1 Infection

Lenacapavir
+3 more

Los Angeles, California
+11 more

Mar 16, 2021